160 related articles for article (PubMed ID: 25208219)
1. Fibronectin affects transient MMP2 gene expression through DNA demethylation changes in non-invasive breast cancer cell lines.
Pereira IT; Ramos EA; Costa ET; Camargo AA; Manica GC; Klassen LM; Chequin A; Braun-Prado K; Pedrosa Fde O; Souza EM; Costa FF; Klassen G
PLoS One; 2014; 9(9):e105806. PubMed ID: 25208219
[TBL] [Abstract][Full Text] [Related]
2. The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells.
Poplineau M; Schnekenburger M; Dufer J; Kosciarz A; Brassart-Pasco S; Antonicelli F; Diederich M; Trussardi-Régnier A
Mol Carcinog; 2015 Jan; 54(1):24-34. PubMed ID: 24038389
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
[TBL] [Abstract][Full Text] [Related]
4. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium.
Das S; Banerji A; Frei E; Chatterjee A
Life Sci; 2008 Feb; 82(9-10):467-76. PubMed ID: 18243246
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.
Bianco C; Castro NP; Baraty C; Rollman K; Held N; Rangel MC; Karasawa H; Gonzales M; Strizzi L; Salomon DS
J Cell Physiol; 2013 Jun; 228(6):1174-88. PubMed ID: 23129342
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways.
Esparza J; Vilardell C; Calvo J; Juan M; Vives J; Urbano-Márquez A; Yagüe J; Cid MC
Blood; 1999 Oct; 94(8):2754-66. PubMed ID: 10515879
[TBL] [Abstract][Full Text] [Related]
7. PAX6 Promoter Methylation Correlates with MDA-MB-231 Cell Migration, and Expression of MMP2 and MMP9.
Urrutia G; Laurito S; Campoy E; Nasif D; Branham MT; Roqué M
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2859-2866. PubMed ID: 30362313
[TBL] [Abstract][Full Text] [Related]
8. MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
Klassen LMB; Chequin A; Manica GCM; Biembengut IV; Toledo MB; Baura VA; de O Pedrosa F; Ramos EAS; Costa FF; de Souza EM; Klassen G
Gene; 2018 Feb; 642():461-466. PubMed ID: 29162512
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2'-deoxycytidine.
Chik F; Machnes Z; Szyf M
Carcinogenesis; 2014 Jan; 35(1):138-44. PubMed ID: 23985780
[TBL] [Abstract][Full Text] [Related]
10. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
[TBL] [Abstract][Full Text] [Related]
11. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
[TBL] [Abstract][Full Text] [Related]
12. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
13. Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer.
Han LL; Hou L; Zhou MJ; Ma ZL; Lin DL; Wu L; Ge YL
J Biomed Sci; 2013 Jul; 20(1):52. PubMed ID: 23899187
[TBL] [Abstract][Full Text] [Related]
14. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer.
Jiao F; Bai SY; Ma Y; Yan ZH; Yue Z; Yu Y; Wang X; Wang J
PLoS One; 2014; 9(3):e92190. PubMed ID: 24632672
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.
Horne HN; Lee PS; Murphy SK; Alonso MA; Olson JA; Marks JR
Mol Cancer Res; 2009 Feb; 7(2):199-209. PubMed ID: 19208741
[TBL] [Abstract][Full Text] [Related]
17. Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells.
Poplineau M; Doliwa C; Schnekenburger M; Antonicelli F; Diederich M; Trussardi-Régnier A; Dufer J
Cell Prolif; 2013 Apr; 46(2):127-36. PubMed ID: 23510467
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.
Chernov AV; Sounni NE; Remacle AG; Strongin AY
J Biol Chem; 2009 May; 284(19):12727-34. PubMed ID: 19286653
[TBL] [Abstract][Full Text] [Related]
19. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
20. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.
Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M
Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
